Related Experiment Video
Updated: Jan 17, 2026

Application of Deep Learning-Based Medical Image Segmentation via Orbital Computed Tomography
Published on: November 30, 2022
OcuMDNet: A lightweight CNN for robust multi-disease retinal diagnosis with cross-dataset reliability
Qianjie Yang1, Vijay Govindarajan2, Qiyuan Li1
1Ningbo Key Laboratory of Medical Research on Blinding Eye Diseases, Ningbo Eye Hospital, Ningbo Eye Institute, Wenzhou Medical University, Ningbo, 315040, China.
None:
This study aims to develop a lightweight convolutional network for the classification of multiple retinal diseases using fundus images and to evaluate cross-dataset generalization under strict label alignment. We introduce OcuMDNet (Ocular Multi-Disease Net), a compact convolutional neural network (CNN) specifically designed for fundus imagery, incorporating batch normalization and dropout for regularization. A standardized processing pipeline is employed, which includes cropping and resizing images to 224 × 224 pixels, applying contrast-limited adaptive histogram equalization (CLAHE), and performing per-channel normalization. The training process utilizes the AdamW optimizer and incorporates early stopping to enhance model performance. We propose a label-aligned evaluation protocol: (i) assesses 4-class performance (Normal, diabetic retinopathy (DR), Glaucoma, age-related macular degeneration (AMD)) on a combined dataset assembled from public sources; (ii) reports disease-specific results based on the native labels of each dataset (DR: EyePACS, Messidor; Glaucoma: ORIGA; AMD: AREDS); and (iii) evaluates cross-dataset transfer for DR (training on EyePACS and testing on Messidor). Patient-level splits are implemented to prevent data leakage, and class counts are reported for each split. Performance metrics such as accuracy, macro-F1 score, and one-vs-rest ROC-AUC are calculated with 95 % confidence intervals using stratified bootstrap (n = 1000). Paired comparisons are conducted using McNemar's test for accuracy and DeLong's method for AUC, with multiplicity control applied. The OcuMDNet demonstrates strong performance on both combined and disease-specific benchmarks, maintaining robust discrimination in cross-dataset evaluations for DR while ensuring computational efficiency suitable for large-scale screening applications. Ablation studies confirm the significance of preprocessing steps and architectural choices. In conjunction with a label-aligned protocol, the OcuMDNet provides an accurate and efficient baseline for multi-disease fundus analysis, facilitating a transparent assessment of cross-dataset reliability. The code, scripts, and trained weights will be made available to support reproducibility.
